{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:13:00Z","timestamp":1787915580993,"version":"build-2784847793"},"reference-count":129,"publisher":"California Digital Library (CDL)","issue":"4","license":[{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WestJEM"],"DOI":"10.5811\/westjem.2019.4.39935","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T17:46:16Z","timestamp":1562694376000},"page":"557-572","source":"Crossref","is-referenced-by-count":49,"title":["Legalized Cannabis in Colorado Emergency Departments: A Cautionary Review of Negative Health and Safety Effects"],"prefix":"10.5811","volume":"20","author":[{"given":"Brad","family":"Roberts","sequence":"first","affiliation":[{"name":"University of New Mexico, Department of Emergency Medicine, Albuquerque, New Mexico Partner, Southern Colorado Emergency Medicine Associates, Pueblo, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"29705","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"key":"ref0","unstructured":"Colorado Division of Criminal Justice Department of Public Safety. Impacts of marijuana legalization in colorado: A report pursuant to senate bill 13-283 2018. Available at: https:\/\/cdpsdocs.state.co.us\/ors\/docs\/reports\/2018-SB13-283_Rpt.pdf. Accessed November 2018."},{"key":"ref1","unstructured":"Ogden Memo: Investigations and Prosecutions in States Authorizing the Medical Use of Marijuana 2009. Available at: https:\/\/www.justice.gov\/archives\/opa\/blog\/memorandum-selected-united-state-attorneys-investigations-and-prosecutions-states. Accessed November 2018."},{"key":"ref2","unstructured":"Cole, Memo: Guidance Regarding Marijuana Enforcement 2013. Available at: https:\/\/www.justice.gov\/iso\/opa\/resources\/3052013829132756857467.pdf. Accessed November 2018."},{"key":"ref3","unstructured":"Sessions nixes Obama-era rules leaving states alone that legalize pot 2018. Available at: https:\/\/www.cnn.com\/2018\/01\/04\/politics\/jeff-sessions-cole-memo\/index.html. Accessed January 2018."},{"key":"ref4","unstructured":"Interactive NSDUH State Estimates: Substance Abuse & Mental Health Data Archives 2015. Available at: https:\/\/pdas.samhsa.gov\/saes\/state. Accessed November 2018."},{"key":"ref5","unstructured":"The health and social effects of non-medical cannabis use 2016. Available at: http:\/\/apps.who.int\/iris\/bitstream\/10665\/251056\/1\/9789241510240-eng.pdf?ua=1. Accessed March 2016."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Wang GS, Hall K, Vigil D, et al. Marijuana and acute health care contacts in Colorado. Prev Med. 2017;104:24-30.","DOI":"10.1016\/j.ypmed.2017.03.022"},{"key":"ref7","unstructured":"Marijuana legalization in Colorado: early findings. A report pursuant to Senate Bill 13-283 2016. Available at: https:\/\/cdpsdocs.state.co.us\/ors\/docs\/reports\/2016-SB13-283-Rpt.pdf. Accessed August 6, 2018."},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Wang GS, Davies SD, Halmo LS, et al. Impact of Marijuana Legalization in Colorado on Adolescent Emergency and Urgent Care Visits. J Adolesc Health. 2018;63(2):239-41.","DOI":"10.1016\/j.jadohealth.2017.12.010"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press 2017.","DOI":"10.17226\/24625"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Andr\u00e9asson S, Allebeck P, Engstrom A, et al. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet. 1987;330(8574):1483-6.","DOI":"10.1016\/s0140-6736(87)92620-1"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Zammit S, Allebeck P, Andreasson S, et al. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ. 2002;325(7374):1199.","DOI":"10.1136\/bmj.325.7374.1199"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"van Os J, Bak M, Hanssen M, et al. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol. 2002;156(4):319-27.","DOI":"10.1093\/aje\/kwf043"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Henquet C, Krabbendam L, Spauwen J,et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ. 2004;330(7481):11.","DOI":"10.1136\/bmj.38267.664086.63"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Arseneault L, Cannon M, Poulton R, et al. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ. 2002;325(7374):1212-3.","DOI":"10.1136\/bmj.325.7374.1212"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Fergusson DM, Horwood LJ, Swain-Campbell NR. Cannabis dependence and psychotic symptoms in young people. Psychol Med. 2003;33(1):15-21.","DOI":"10.1017\/s0033291702006402"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Stefanis NC, Dragovic M, Power BD, et al. The effect of drug use on the age at onset of psychotic disorders in an Australian cohort. Schizophr Res. 2014;156(2\u20133):211-6.","DOI":"10.1016\/j.schres.2014.04.003"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370(9584):319-28.","DOI":"10.1016\/s0140-6736(07)61162-3"},{"key":"ref18","unstructured":"Libuy N, Angel V, Ib\u00e1\u00f1ez C. Risk of schizophrenia in marijuana users: findings from a nationwide sample of drug users in Chile. 2015. National Institute on Drug Abuse."},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Di Forti M, Sallis H, Allegri F, et al. Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr Bull. 2014;40(6):1509-17.","DOI":"10.1093\/schbul\/sbt181"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Lev-Ran S, Roerecke M, Le Foll B, et al. The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychol Med. 2014;44(4):797-810.","DOI":"10.1017\/s0033291713001438"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Kedzior KK, Laeber LT. A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population - a meta-analysis of 31 studies. BMC Psychiatry. 2014;14:136.","DOI":"10.1186\/1471-244x-14-136"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Borges G, Bagge CL, Orozco R. A literature review and meta-analyses of cannabis use and suicidality. J Affect Disord. 2016;195:63-74.","DOI":"10.1016\/j.jad.2016.02.007"},{"key":"ref23","unstructured":"Suicides in Colorado: methods, circumstances, and toxicology.\u00a0Colorado Violent Death Reporting System 2016. Available at: https:\/\/cohealthviz.dphe.state.co.us\/t\/HSEBPublic\/views\/CoVDRS_12_1_17\/Story1?:embed=y&:showAppBanner=false&:showShareOptions=true&:display_count=no&:showVizHome=no#4. Accessed August 2018."},{"key":"ref24","unstructured":"Implications of legalized cannabis in Colorado emergency departments, Colorado Department of Public Health and Environment. Available at: https:\/\/drive.google.com\/file\/d\/126A5GxdZWp2375pU14iXFq2T3s9ubZSl\/view. Accessed July 11, 2018."},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Danielsson A, Falkstedt D, Hemmingsson T, et al. Cannabis use among Swedish men in adolescence and the risk of adverse life course outcomes: results from a 20-year follow-up study. Addiction. 2015;110(11):1794-802.","DOI":"10.1111\/add.13042"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Fergusson DM, Boden JM. Cannabis use and later life outcomes. Addiction. 2008;103(6):969-76.","DOI":"10.1111\/j.1360-0443.2008.02221.x"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Fergusson DM, Boden JM, Horwood LJ. Psychosocial sequelae of cannabis use and implications for policy: findings from the Christchurch Health and Development Study. Soc Psychiatry Psychiatr Epidemiol. 2015;50(9):1317-26.","DOI":"10.1007\/s00127-015-1070-x"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Zhang C, Brook JS, Leukefeld CG, et al. Trajectories of marijuana use from adolescence to adulthood as predictors of unemployment status in the early forties. Am J Addict. 2016;25(3):203-9.","DOI":"10.1111\/ajad.12361"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Volkow ND, Baler RD, Compton WM, et al. Adverse health effects of marijuana use. N Engl J Med. 2014;370(23):2219-27.","DOI":"10.1056\/nejmra1402309"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet. 2009;374(9698):1383-91.","DOI":"10.1016\/s0140-6736(09)61037-0"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Sagar KA, Gruber SA. Marijuana matters: reviewing the impact of marijuana on cognition, brain structure and function, & exploring policy implications and barriers to research. Int Rev Psychiatry. 2018;30(3):251-67.","DOI":"10.1080\/09540261.2018.1460334"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Memedovich KA, Dowsett LE, Spackman E, et al. The adverse health effects and harms related to marijuana use: an overview review. CMAJ Open. 2018;6(3):E339-46.","DOI":"10.9778\/cmajo.20180023"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Batalla A, Bhattacharyya S, Y\u00fccel M, et al. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS One. 2013;8(2):e55821.","DOI":"10.1371\/journal.pone.0055821"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Lorenzetti V, Lubman DI, Whittle S, Solowij N, et al. Structural MRI findings in long-term cannabis users: what do we know? Subst Use Misuse. 2010;45(11):1787-808.","DOI":"10.3109\/10826084.2010.482443"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Rocchetti M, Crescini A, Borgwardt S, et al. Is cannabis neurotoxic for the healthy brain? A meta-analytical review of structural brain alterations in non-psychotic users. Psychiatry Clin Neurosci. 2013;67(7):483-92.","DOI":"10.1111\/pcn.12085"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Cousijn J, Wiers RW, Ridderinkhof KR, et al. Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. NeuroImage. 2012;59(4):3845-51.","DOI":"10.1016\/j.neuroimage.2011.09.046"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Y\u00fccel M, Solowij N, Respondek C, et al. Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry. 2008;65(6):694-701.","DOI":"10.1001\/archpsyc.65.6.694"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Churchwell J, Lopez-Larson M, Yurgelun-Todd D. Altered frontal cortical volume and decision making in adolescent cannabis users. Front Psychol. 2010;1:225.","DOI":"10.3389\/fpsyg.2010.00225"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Gruber SA, Yurgelun-Todd DA. Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation. Brain Res Cogn Brain Res. 2005;23(1):107-18.","DOI":"10.1016\/j.cogbrainres.2005.02.016"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Wrege J, Schmidt A, Walter A, Smieskova R, et al. Effects of cannabis on impulsivity: a systematic review of neuroimaging findings. Curr Pharm Des. 2014;20(13)2126-37.","DOI":"10.2174\/13816128113199990428"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Blanco-Hinojo L, Pujol J, Harrison BJ, et al. Attenuated frontal and sensory inputs to the basal ganglia in cannabis users. Addict Biol. 2017;22(4):1036-47.","DOI":"10.1111\/adb.12370"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Filbey F, Yezhuvath U. Functional connectivity in inhibitory control networks and severity of cannabis use disorder. Am J Drug Alcohol. Abuse 2013;39(6):382-91.","DOI":"10.3109\/00952990.2013.841710"},{"key":"ref43","unstructured":"Camchong J, Lim KO, Kumra S. Adverse effects of cannabis on adolescent brain development: a longitudinal study. Cerebral Cortex. 2017;27(3):1922-30."},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Fischer AS, Whitfield-Gabrieli S, Roth RM, et al. Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THC. Schizophr Res. 2014;158(1):176-82.","DOI":"10.1016\/j.schres.2014.04.033"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Zalesky A, Solowij N, Y\u00fccel M, et al. Effect of long-term cannabis use on axonal fibre connectivity. Brain. 2012;135(7):2245-55.","DOI":"10.1093\/brain\/aws136"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Colizzi M, McGuire P, Pertwee RG, et al. Effect of cannabis on glutamate signalling in the brain: a systematic review of human and animal evidence. Neurosci Biobehav Rev. 2016;64:359-81.","DOI":"10.1016\/j.neubiorev.2016.03.010"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Sami MB, Rabiner EA, Bhattacharyya S. Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date. Eur Neuropsychopharmacol. 2015;25(8):1201-24.","DOI":"10.1016\/j.euroneuro.2015.03.011"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Sneider JT, Mashhoon Y, Silveri MM. A review of magnetic resonance sepctroscopy studies in marijuana using adolescents and adults. J Addict Res Ther. 2013;4(10).","DOI":"10.4172\/2155-6105.s4-010"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Swift W, Coffey C, Degenhardt L, et al. Cannabis and progression to other substance use in young adults: Findings from a 13-year prospective population-based study. J Epidemiol Community Health. 2012;66(7):e26.","DOI":"10.1136\/jech.2010.129056"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Silins E, Swift W, Slade T, et al. A prospective study of the substance use and mental health outcomes of young adult former and current cannabis users. Drug Alcohol Rev. 2017;36(5):618-25.","DOI":"10.1111\/dar.12512"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Taylor M, Collin SM, Munaf\u00f2 M,R., et al. Patterns of cannabis use during adolescence and their association with harmful substance use behaviour: findings from a UK birth cohort. J Epidemiol Community Health. 2017;71(8):764-70.","DOI":"10.1136\/jech-2016-208503"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Agrawal A, Neale M, Prescott C, et al. A twin study of early cannabis use and subsequent use and abuse\/dependence of other illicit drugs. Psychol Med. 2004;34(7)1227-37.","DOI":"10.1017\/s0033291704002545"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Grant JD, Lynskey MT, Scherrer JF, et al. A co-twin control analysis of drug use and abuse\/dependence risk associated with early-onset cannabis use. Addict Behav. 2010;35(1):35-41.","DOI":"10.1016\/j.addbeh.2009.08.006"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Lynskey MT, Heath AC, Bucholz KK, et al. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA. 2003;289(4):427-33.","DOI":"10.1001\/jama.289.4.427"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Lynskey MT, Vink JM, Boomsma DI. Early onset cannabis use and progression to other drug use in a sample of Dutch twins. Behav Genet. 2006;36(2):195-200.","DOI":"10.1007\/s10519-005-9023-x"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Bachhuber M, Saloner B, Cunningham C, et al. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Intern Med. 2014;174(10):1668-73.","DOI":"10.1001\/jamainternmed.2014.4005"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Livingston MD, Barnett TE, Delcher C, et al. Recreational cannabis legalization and opioid-related deaths in Colorado, 2000\u20132015. Am J Public Health. 2017;107(11):1827-9.","DOI":"10.2105\/ajph.2017.304059"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Cadoni C, Pisanu A, Solinas M, et al. Behavioural sensitization after repeated exposure to \u00ce\u201d9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology (Berl). 2001;158(3):259-66.","DOI":"10.1007\/s002130100875"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Panlilio LV, Zanettini C, Barnes C, et al. Prior exposure to THC increases the addictive effects of nicotine in rats. Neuropsychopharmacology. 2013;38(7):1198-208.","DOI":"10.1038\/npp.2013.16"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Pistis M, Perra S, Pillolla G, et al. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biol Psychiatry. 2004;56(2):86-94.","DOI":"10.1016\/j.biopsych.2004.05.006"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Cadoni C, Valentini V, Di Chiara G. Behavioral sensitization to \u03949-tetrahydrocannabinol and cross-sensitization with morphine: Differential changes in accumbal shell and core dopamine transmission. J Neurochem. 2008;106(4):1586-93.","DOI":"10.1111\/j.1471-4159.2008.05503.x"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Ledent C, Valverde O, Cossu G, et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science. 1999;283(5400):401-4.","DOI":"10.1126\/science.283.5400.401"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"van der Pol P, Liebregts N, de Graaf R, et al. Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. Drug Alcohol Depend. 2016;133(2):352-9.","DOI":"10.1016\/j.drugalcdep.2013.06.009"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Swift W, Coffey C, Carlin JB, et al. Adolescent cannabis users at 24 years: trajectories to regular weekly use and dependence in young adulthood. Addiction. 2008;103(8):1361-70.","DOI":"10.1111\/j.1360-0443.2008.02246.x"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Lopez-Quintero C, Perez de los Cobos J, Hasin DS, et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2010;115(1-2):120-30.","DOI":"10.1016\/j.drugalcdep.2010.11.004"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Hasin DS, Saha TD, Kerridge BT, et al. Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry. 2015;72(12):1235-42.","DOI":"10.1001\/jamapsychiatry.2015.1858"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Lapoint J, Meyer S, Yu CK, et al. Cannabinoid hyperemesis syndrome: public health implications and a novel model treatment guideline. West J  Emerg Med. 2017;19(2):380-6.","DOI":"10.5811\/westjem.2017.11.36368"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Sorensen C, DeSanto K, Borgelt L, et al. Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment\u2014a systematic review. J Med Toxicol. 2017;13(1):71-87.","DOI":"10.1007\/s13181-017-0610-z"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Parekh JD, Wozniak SE, Khan K, et al. Cannabinoid hyperemesis syndrome. BMJ Case Rep. 2016;bcr2015213620.","DOI":"10.1136\/bcr-2015-213620"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Kim HS, Anderson JD, Saghafi O, et al. Cyclic vomiting presentations following marijuana liberalization in Colorado. Acad Emerg Med. 2015;22(6):694-9.","DOI":"10.1111\/acem.12655"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Hernandez JM, Paty J, Price IM. Cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multicentre retrospective chart review in a major urban area. CJEM. 2018;20(4):550-5.","DOI":"10.1017\/cem.2017.381"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Salomonsen-Sautel S, Min S, Sakai JT, et al. Trends in fatal motor vehicle crashes before and after marijuana commercialization in Colorado. Drug Alcohol Depend. 2014;140:137-44.","DOI":"10.1016\/j.drugalcdep.2014.07.004"},{"key":"ref73","unstructured":"Drugged driving statistics [Internet]; c2016 [cited 2018 07\/11]. Available at: https:\/\/www.codot.gov\/safety\/alcohol-and-impaired-driving\/druggeddriving\/drugged-driver-statistics\/view. Accessed July 2018."},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Monitoring health concerns\u00a0related to marijuana in Colorado: 2016 changes in marijuana use patterns, systematic literature review, and possible marijuana-related health effects [Internet]; c2016 [cited 2018 August 8]. Available at: https:\/\/www.colorado.gov\/pacific\/cdphe\/retail-marijuana-public-health-advisory-committee. Accessed August 2018.","DOI":"10.1007\/s11121-018-0933-2"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ. 2012;344:e536.","DOI":"10.1136\/bmj.e536"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Aydelotte JD, Brown LH, Luftman KM, et al. Crash fatality rates after recreational marijuana legalization in Washington and Colorado. Am J Public Health. 2017;107(8):1329-31.","DOI":"10.2105\/ajph.2017.303848"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Alfulaij N, Meiners F, Michalek J, et al. Cannabinoids, the heart of the matter. J Am Heart Assoc. 2018;7(14):e009099.","DOI":"10.1161\/JAHA.118.009099"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Hodcroft CJ, Rossiter MC, Buch AN. Cannabis-associated myocardial infarction in a young man with normal coronary arteries. J Emerg Med. 2014;47(3):277-81.","DOI":"10.1016\/j.jemermed.2013.11.077"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Velibey Y, Sahin S, Tan\u0131k O, et al. Acute myocardial infarction due to marijuana smoking in a young man: guilty should not be underestimated. Am J Emerg Med. 2015;33(8):1114.e1-3.","DOI":"10.1016\/j.ajem.2015.01.032"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"Caldicott DGE, Holmes J, Roberts-Thomson K, et al. Keep off the grass: marijuana use and acute cardiovascular events. Eur J Emerg Med. 2005;12(5):236-44.","DOI":"10.1097\/00063110-200510000-00008"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Hackam DG. Cannabis and stroke: systematic appraisal of case reports. Stroke. 2015;46(3):852-6.","DOI":"10.1161\/strokeaha.115.008680"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Mittleman MA, Lewis RA, Malcolm M, et al. Triggering myocardial infarction by marijuana. Circulation. 2001;103(23):2805-9.","DOI":"10.1161\/01.cir.103.23.2805"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Patel RS, Katta SR, Patel R, et al. Cannabis use disorder in young adults with acute myocardial infarction: trend inpatient study from 2010 to 2014 in the United States. Cureus. 2018;10(8):e3241.","DOI":"10.7759\/cureus.3241"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Wang X, Derakhshandeh R, Liu J, et al. One minute of marijuana secondhand smoke exposure substantially impairs vascular endothelial function. J Am Heart Assoc. 2016;5(8).","DOI":"10.1161\/jaha.116.003858"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"Singh A, Saluja S, Kumar A, et al. Cardiovascular complications of marijuana and related substances: a review. Cardiol Ther. 2018;7(1):45-59.","DOI":"10.1007\/s40119-017-0102-x"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Benowitz NL, Rosenberg J, Rogers W, et al. Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms. Clin Pharmacol Ther. 1979;25(4):440-6.","DOI":"10.1002\/cpt1979254440"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Gash A, Karliner JS, Janowsky D, et al. Effects of smoking marihuana on left ventricular performance and plasma norepinephrine: studies in normal men. Ann Intern Med. 1978;89(4):448-52.","DOI":"10.7326\/0003-4819-89-4-448"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"Jones RT. Cardiovascular system effects of marijuana. J Clin Pharmacol. 2002;42(S1):58S-63S.","DOI":"10.1002\/j.1552-4604.2002.tb06004.x"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Wu T, Tashkin DP, Djahed B, et al. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med. 1988;318(6):347-51.","DOI":"10.1056\/nejm198802113180603"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Aronow WS, Cassidy J. Effect of marihuana and placebo-marihuana smoking on angina pectoris. N Engl J Med. 1974;291(2):65-7.","DOI":"10.1056\/nejm197407112910203"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Goyal H, Awad HH, Ghali JK. Role of cannabis in cardiovascular disorders. J Thorac Dis. 2017;9(7):2079-92.","DOI":"10.21037\/jtd.2017.06.104"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Malinowska B, Baranowska-Kuczko M, Schlicker E. Triphasic blood pressure responses to cannabinoids: Do we understand the mechanism? Br J Pharmacol. 2012;165(7):2073-88.","DOI":"10.1111\/j.1476-5381.2011.01747.x"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"Ducros A, Boukobza M, Porcher R, et al. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007;130(Pt 12):3091-101.","DOI":"10.1093\/brain\/awm256"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"Disdier P, Granel B, Serratrice J, et al. Cannabis arteritis revisited: ten new case reports. Angiology. 2001;52(1):1-5.","DOI":"10.1177\/000331970105200101"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"Thomas G, Kloner RA, Rezkalla S. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Am J Cardiol. 2014;113(1):187-90.","DOI":"10.1016\/j.amjcard.2013.09.042"},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"Herning RI, Better WE, Tate K, et al. Cerebrovascular perfusion in marijuana users during a month of monitored abstinence. Neurology. 2005;64(3):488-93.","DOI":"10.1212\/01.wnl.0000150882.69371.dd"},{"key":"ref97","doi-asserted-by":"publisher","unstructured":"Quercioli A, Pataky Z, Vincenti G, et al. Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity. Eur Heart J. 2011;32(11):1369-78.","DOI":"10.1093\/eurheartj\/ehr029"},{"key":"ref98","doi-asserted-by":"publisher","unstructured":"Lipina C, Hundal HS. Modulation of cellular redox homeostasis by the endocannabinoid system. Open Biol. 2016;6(4):150276.","DOI":"10.1098\/rsob.150276"},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"Williams JC, Klein TW, Goldberger BA, et al. Delta(9)-tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles. J Inflamm (Lond). 2015;12:39.","DOI":"10.1186\/s12950-015-0084-1"},{"key":"ref100","doi-asserted-by":"publisher","unstructured":"Deusch E, Kress HG, Kraft B, Kozek-Langenecker SA. The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets. Anesth Analg. 2004;99(4):1127,30.","DOI":"10.1213\/01.ane.0000131505.03006.74"},{"key":"ref101","doi-asserted-by":"publisher","unstructured":"Tetrault JM, Crothers K, Moore BA, et al. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med. 2007;167(3):221-8.","DOI":"10.1001\/archinte.167.3.221"},{"key":"ref102","doi-asserted-by":"publisher","unstructured":"Aldington S, Williams M, Nowitz M, et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax. 2007;62(12):1058-63.","DOI":"10.1136\/thx.2006.077081"},{"key":"ref103","doi-asserted-by":"publisher","unstructured":"Wang G, Le Lait M, Deakyne SJ, et al. Unintentional pediatric exposures to marijuana in Colorado, 2009-2015. JAMA Pediatr. 2016;170(9):e160971.","DOI":"10.1001\/jamapediatrics.2016.0971"},{"key":"ref104","doi-asserted-by":"publisher","unstructured":"Wang GS, Hoyte C, Roosevelt G, et al. The continued impact of marijuana legalization on unintentional pediatric exposures in Colorado. Clin Pediatr (Phila). 2019;58(1):114-6.","DOI":"10.1177\/0009922818805206"},{"key":"ref105","doi-asserted-by":"publisher","unstructured":"Vo KT, Horng H, Li K, et al. Cannabis Intoxication Case Series: The dangers of edibles containing tetrahydrocannabinol. Ann Emerg Med. 2018;71(3):306-13.","DOI":"10.1016\/j.annemergmed.2017.09.008"},{"key":"ref106","doi-asserted-by":"publisher","unstructured":"Dryburgh LM, Bolan NS, Grof CPL, et al. Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. Br J Clin Pharmacol. 2018;84(11):2468-76.","DOI":"10.1111\/bcp.13695"},{"key":"ref107","doi-asserted-by":"crossref","unstructured":"Russo EB. Current therapeutic cannabis controversies and clinical trial design issues. Front in Pharmacol. 2016;7:309.","DOI":"10.3389\/fphar.2016.00309"},{"key":"ref108","doi-asserted-by":"publisher","unstructured":"Chandra S, Radwan MM, Majumdar CG, et al. New trends in cannabis potency in USA and Europe during the last decade (2008-2017). Eur Arch Psychiatry Clin Neurosci. 2019;269(1):5-15.","DOI":"10.1007\/s00406-019-00983-5"},{"key":"ref109","doi-asserted-by":"publisher","unstructured":"Raber JC, Elzinga S, Kaplan C. Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. J Toxicol Sci. 2015;40(6):797-803.","DOI":"10.2131\/jts.40.797"},{"key":"ref110","doi-asserted-by":"publisher","unstructured":"Pierre JM, Gandal M, Son M. Cannabis-induced psychosis associated with high potency \u201cwax dabs.\u201d Schizophr Res. 2016;172(1-3):211-2.","DOI":"10.1016\/j.schres.2016.01.056"},{"key":"ref111","doi-asserted-by":"publisher","unstructured":"Cinnamon Bidwell L, YorkWilliams SL, Mueller RL, et al. Exploring cannabis concentrates on the legal market: user profiles, product strength, and health-related outcomes. Addict Behav Rep. 2018;8:102-6.","DOI":"10.1016\/j.abrep.2018.08.004"},{"key":"ref112","doi-asserted-by":"publisher","unstructured":"Al-Zouabi I, Stogner JM, Miller BL, et al. Butane hash oil and dabbing: insights into use, amateur production techniques, and potential harm mitigation. Subst Abuse Rehabil. 2018;9:91-101.","DOI":"10.2147\/sar.s135252"},{"key":"ref113","doi-asserted-by":"publisher","unstructured":"Romanowski KS, Barsun A, Kwan P, et al. Butane hash oil burns: a 7-year perspective on a growing problem. J Burn Care Res. 2017;38(1):e165-71.","DOI":"10.1097\/bcr.0000000000000334"},{"key":"ref114","doi-asserted-by":"publisher","unstructured":"Bell C, Slim J, Flaten HK, et al. Butane hash oil burns associated with marijuana liberalization in Colorado. J Med Toxicol. 2015;11(4):422-5.","DOI":"10.1007\/s13181-015-0501-0"},{"key":"ref115","doi-asserted-by":"publisher","unstructured":"Dickson B, Mansfield C, Guiahi M, et al. Recommendations from cannabis dispensaries about first-trimester cannabis use. Obstet & Gynecol. 2018;131(6)1031-8.","DOI":"10.1097\/aog.0000000000002619"},{"key":"ref116","unstructured":"Eid BG. Cannabinoids for treating cardiovascular disorders: putting together a complex puzzle. J Microsc Ultrastruct. 2018;6(4):171-6."},{"key":"ref117","doi-asserted-by":"publisher","unstructured":"Devinsky O, Cross JH, Laux L, et al. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med. 2017;376:2011-20.","DOI":"10.1056\/nejmoa1611618"},{"key":"ref118","doi-asserted-by":"publisher","unstructured":"Thiele EA, Marsh ED, French JA, et al. Cannabidiol in patients with seizures associated with lennox-gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2018;391(10125):1085-96.","DOI":"10.3410\/f.732604915.793556785"},{"key":"ref119","unstructured":"Medical marijuana and epilepsy 2018. Available at: https:\/\/www.epilepsy.com\/learn\/treating-seizures-and-epilepsy\/other-treatment-approaches\/medical-marijuana-and-epilepsy. Accessed July 2018."},{"key":"ref120","unstructured":"Sativex oromucosal spray 2015. Available at: https:\/\/www.medicines.org.uk\/emc\/product\/602\/smpc. Accessed July 11, 2018."},{"key":"ref121","doi-asserted-by":"publisher","unstructured":"Bonn-Miller MO, Loflin ME, Thomas BF, et al. Labeling accuracy of cannabidiol extracts sold online. JAMA. 2017;318(17):1708-9.","DOI":"10.1001\/jama.2017.11909"},{"key":"ref122","doi-asserted-by":"publisher","unstructured":"Vandrey R, Raber JC, Raber ME, et al. Cannabinoid dose and label accuracy in edible medical cannabis products. JAMA. 2015;313(24):2491-3.","DOI":"10.1001\/jama.2015.6613"},{"key":"ref123","doi-asserted-by":"publisher","unstructured":"M\u00fccke M, Phillips T, Radbruch L, et al. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2018;3:CD012182.","DOI":"10.1002\/14651858.cd012182.pub2"},{"key":"ref124","doi-asserted-by":"publisher","unstructured":"Hall W, West R, Marsden J, et al. It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis. Addiction. 2018;113(6):987-8.","DOI":"10.1111\/add.14139"},{"key":"ref125","doi-asserted-by":"publisher","unstructured":"Wen H, Hockenberry JM. Association of medical and adult-use marijuana laws with opioid prescribing for Medicaid enrollees. JAMA Intern Med. 2018;178(5):673-9.","DOI":"10.1001\/jamainternmed.2018.1007"},{"key":"ref126","doi-asserted-by":"publisher","unstructured":"Campbell G, Hall WD, Peacock A, et al. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study. Lancet Public Health. 2018;3(7):e341-50.","DOI":"10.1016\/s2468-2667(18)30110-5"},{"key":"ref127","doi-asserted-by":"crossref","unstructured":"Olfson M, Wall MM, Liu S, et al. Cannabis use and risk of prescription opioid use disorder in the United States. Am J Psychiatry. 2017;175(1):47-53.","DOI":"10.1176\/appi.ajp.2017.17040413"},{"key":"ref128","doi-asserted-by":"publisher","unstructured":"Mead A. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law. Epilepsy Behav. 2017;70(Pt B):288-91.","DOI":"10.1016\/j.yebeh.2016.11.021"}],"container-title":["Western Journal of Emergency Medicine"],"original-title":[],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T17:46:40Z","timestamp":1562694400000},"score":1,"resource":{"primary":{"URL":"https:\/\/escholarship.org\/uc\/item\/6xb8q31x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,3]]},"references-count":129,"issue-title":["Western Journal of Emergency Medicine"],"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,7,5]]}},"URL":"https:\/\/doi.org\/10.5811\/westjem.2019.4.39935","relation":{},"ISSN":["1936-900X"],"issn-type":[{"value":"1936-900X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,3]]}}}